Yatscoff R - Search Results

1

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.

Furlong T, Martin P, Flowers ME, Carnevale-Schianca F, Yatscoff R, Chauncey T, Appelbaum FR, Deeg HJ, Doney K, Witherspoon R, Storer B, Sullivan KM, Storb R, Nash RA. Furlong T, et al. Among authors: yatscoff r. Bone Marrow Transplant. 2009 Dec;44(11):739-48. doi: 10.1038/bmt.2009.76. Epub 2009 Apr 20. Bone Marrow Transplant. 2009. PMID: 19377515 Free PMC article. Clinical Trial.

2

Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measurement of inosine monophosphate dehydrogenase activity in a canine model.

Langman LJ, Shapiro AM, Lakey JR, LeGatt DF, Kneteman NM, Yatscoff RW. Langman LJ, et al. Among authors: yatscoff rw. Transplantation. 1996 Jan 15;61(1):87-92. doi: 10.1097/00007890-199601150-00018. Transplantation. 1996. PMID: 8560580

3

Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients.

Langman LJ, LeGatt DF, Halloran PF, Yatscoff RW. Langman LJ, et al. Among authors: yatscoff rw. Transplantation. 1996 Sep 15;62(5):666-72. doi: 10.1097/00007890-199609150-00022. Transplantation. 1996. PMID: 8830834 Clinical Trial.

4

Combined immunosuppression with cyclosporine, rapamycin, and mycophenolate mofetil controls rejection with minimal nutritional impact in experimental small intestinal transplantation.

Sigalet DL, Thorne PC, Martin GR, Garola RE, Yatscoff RW. Sigalet DL, et al. Among authors: yatscoff rw. Transplant Proc. 2002 Jun;34(4):1121-3. doi: 10.1016/s0041-1345(02)02794-x. Transplant Proc. 2002. PMID: 12072293 No abstract available.

5

Mycophenolate mofetil: a report of the consensus panel.

Shaw LM, Sollinger HW, Halloran P, Morris RE, Yatscoff RW, Ransom J, Tsina I, Keown P, Holt DW, Lieberman R, et al. Shaw LM, et al. Among authors: yatscoff rw. Ther Drug Monit. 1995 Dec;17(6):690-9. doi: 10.1097/00007691-199512000-00025. Ther Drug Monit. 1995. PMID: 8588243 Review. No abstract available.

6

Current opinions on therapeutic drug monitoring of immunosuppressive drugs.

Shaw LM, Holt DW, Keown P, Venkataramanan R, Yatscoff RW. Shaw LM, et al. Among authors: yatscoff rw. Clin Ther. 1999 Oct;21(10):1632-52; discussion 1631. doi: 10.1016/S0149-2918(99)80044-7. Clin Ther. 1999. PMID: 10566561 Free article.

7

Pharmacokinetics of rapamycin.

Yatscoff RW. Yatscoff RW. Transplant Proc. 1996 Apr;28(2):970-3. Transplant Proc. 1996. PMID: 8623483 Review.

8

Effect of combined immunosuppressive drug therapy on small intestinal nutrient transport in the rat.

Sigalet DL, Thorne PC, Williams DC, Martin GR, Yatscoff RW. Sigalet DL, et al. Among authors: yatscoff rw. Clin Biochem. 1999 Feb;32(1):51-7. doi: 10.1016/s0009-9120(98)00083-6. Clin Biochem. 1999. PMID: 10074892

9

The monitoring of immunosuppressive drugs: a pharmacodynamic approach.

Yatscoff RW, Aspeslet LJ. Yatscoff RW, et al. Ther Drug Monit. 1998 Oct;20(5):459-63. doi: 10.1097/00007691-199810000-00002. Ther Drug Monit. 1998. PMID: 9780118 Review.

10

Efficacy of rapamycin, RS-61443, and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts.

Yatscoff RW, Wang S, Keenan R, Chackowsky P, Koshal A. Yatscoff RW, et al. Transplant Proc. 1994 Jun;26(3):1271-3. Transplant Proc. 1994. PMID: 8029905 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page